TOMEGAVAX, INC.
AcquiredPortland, United States · Founded 2016
- Headquarters
- Portland, Oregon
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Acquired by
- Vir BiotechnologySep 2016
About
TomegaVax was a Portland, Oregon immunotherapy company built around CMV-vectored vaccine technology developed at OHSU's Vaccine and Gene Therapy Institute, targeting HIV, malaria, tuberculosis, herpes, and hepatitis. The company was acquired by Vir Biotechnology in January 2017, merging its vaccine platform into Vir's infectious disease portfolio backed by ARCH Venture Partners and the Bill & Melinda Gates Foundation.
Summary
TOMEGAVAX, INC. is a Biotech company based in Portland, United States, founded in 2016.
Funding History
Sep 2016
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tomegavax-inc"><img src="https://indexed.vc/api/badge/company/tomegavax-inc" alt="TOMEGAVAX, INC. on Indexed.vc" width="260" height="76" /></a>